Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin receives FDA approval for generic Potassium Chloride Oral Solution USP
It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis
Zydus Cadila gets USFDA nod to market 2 products
Gemfibrozil tablets are used together with diet to treat very high cholesterol and triglyceride levels in people with…
AstraZeneca’s lupus drug fails to meet main goal in study
AstraZeneca's anifrolumab, which is given intravenously, was being developed for lupus, a chronic autoimmune disease with limited…
HC asks guilty pharma co to give ₹1.50 cr for Kerala flood relief
The court was hearing a suit filed by Glenmark Pharmaceuticals against Galpha Laboratories for allegedly infringing upon its…
Jiva Ayurveda, Gargi College, introduces six-month Ayurveda and Yoga course
The launch of the course in Gargi College is part of Jiva Ayurveda’s ongoing initiative to propagate the knowledge of Ayurveda…
Endothelial progenitor cells are safe for treating stroke patients, reveals study
Eighteen patients were recruited for the randomized, single-blinded study
Panacea Biotec inks Tripartite agreement with Natco Pharma, Breckenridge Pharmaceutical
As per the agreement the Panacea will manufacture and supply of Azacitidine injection in the US market
Lupin gets US FDA nod to market postherpetic neuralgia drug
The company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths
Cadila gets five observations from US FDA
The inspection was conducted at its subsidiary Liva Pharmaceuticals' injectables manufacturing facility in Vadodara